Randomized clinical trial eligibility rates for chemotherapy (CT) and antiangiogenic therapy (AAT) in a population-based cohort of newly diagnosed non-small cell lung cancer (NSCLC) patients
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: L. Fehrenbacher, L. Ackerson, C. Somkin
Institutions: Kaiser Permanente, Kaiser Permanente Vallejo Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2214259081
